Dimitrios P. Kontoyiannis

Top papers

• Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases

  Maureen Roden, Theoklis E. Zaoutis, Wendy Buchanan, et al.·2005·Clinical Infectious Diseases
  ↗ 2,999OA
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

  Thomas F. Patterson, George R. Thompson, David W. Denning, et al.·2016·Clinical Infectious Diseases
  ↗ 2,765OA
• Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

  J. Peter Donnelly, Sharon Chen, Carol A. Kauffman, et al.·2019·Clinical Infectious Diseases
  ↗ 2,735OA
• Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

  Thomas J. Walsh, Elias Anaissie, David W. Denning, et al.·2008·Clinical Infectious Diseases
  ↗ 2,694OA
• Epidemiology and Clinical Manifestations of Mucormycosis

  G. Petrikkos, Anna Skiada, Olivier Lortholary, et al.·2012·Clinical Infectious Diseases
  ↗ 1,445
• Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

  Dimitrios P. Kontoyiannis, Kieren A. Marr, Benjamin J. Park, et al.·2010·Clinical Infectious Diseases
  ↗ 1,431OA
• Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

  Johan Maertens, Issam Raad, Kieren A. Marr, et al.·2015·The Lancet
  ↗ 959
• Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

  Georgios Chamilos, Russell E. Lewis, Dimitrios P. Kontoyiannis·2008·Clinical Infectious Diseases
  ↗ 802OA
• Pathogenesis of Mucormycosis

  Ashraf S. Ibrahim, Brad Spellberg, Thomas J. Walsh, et al.·2012·Clinical Infectious Diseases
  ↗ 793OA
• Glucocorticoids and invasive fungal infections

  Michail S. Lionakis, Dimitrios P. Kontoyiannis·2003·The Lancet
  ↗ 665
• Antifungal drug resistance of pathogenic fungi

  Dimitrios P. Kontoyiannis, Russell E. Lewis·2002·The Lancet
  ↗ 558
• Recent Advances in the Management of Mucormycosis: From Bench to Bedside

  Brad Spellberg, Thomas J. Walsh, Dimitrios P. Kontoyiannis, et al.·2009·Clinical Infectious Diseases
  ↗ 543OA